COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Video Library
Leading transplant experts share vital information to help you make informed healthcare decisions before and after transplant.
You are here
Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Managing Vaginal Graft-versus-Host Disease (GVHD)
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
